You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RSVPreF3 vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Infections Trial (RSVPreF3 vaccine, Control)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 vaccine
  • Control
  • (no location specified)
Jan 20, 2023

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • PCV20
  • (no location specified)
May 18, 2023

RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (RSVpreF 120 µg, RSVpreF 60 µg, )

Not yet recruiting
  • RESPIRATORY SYNCYTIAL VIRUS (RSV)
  • RSVpreF 120 µg
  • +2 more
  • (no location specified)
Jun 2, 2023

Respiratory Syncytial Viruses Trial in Canada, United Kingdom, United States (RSVPreF3 OA investigational vaccine, HZ/su

Not yet recruiting
  • Respiratory Syncytial Viruses
  • RSVPreF3 OA investigational vaccine
  • HZ/su vaccine
  • Daphne, Alabama
  • +23 more
Jul 21, 2023

Respiratory Syncytial Virus Infections Trial in Belgium, United States (RSVPreF3 OA investigational vaccine (GSK3844766A))

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine (GSK3844766A)
  • Lenexa, Kansas
  • +9 more
Jun 2, 2022

Respiratory Syncytial Virus Infections Trial in New Zealand, Panama, South Africa (RSVPreF3 OA investigational vaccine, FLU-QIV)

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • FLU-QIV
  • Auckland, New Zealand
  • +13 more
Sep 20, 2022

RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (Substudy A (Study Intervention), Substudy A (Placebo), Substudy B)

Not yet recruiting
  • RESPIRATORY SYNCYTIAL VIRUS (RSV)
  • Substudy A (Study Intervention)
  • +2 more
  • (no location specified)
Apr 24, 2023

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • FLU vaccine
  • Edegem, Belgium
  • +33 more
Dec 7, 2022

Respiratory Syncytial Virus Infections Trial in Belgium, Canada, United States (RSVPreF3 formulation 3, RSVPreF3 formulation 2,

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 formulation 3
  • +4 more
  • Miami, Florida
  • +7 more
Nov 12, 2021

Respiratory Syncytial Virus Infections Trial in Canada, Sweden, United States (RSVPreF3 OA investigational vaccine)

Completed
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Waterbury, Connecticut
  • +19 more
Aug 5, 2022

Respiratory Syncytial Virus Infections Trial in United States (RSVPreF3 OA investigational vaccine, FLU HD vaccine)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • FLU HD vaccine
  • Birmingham, Alabama
  • +46 more
Jan 12, 2023

Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA Investigational Vaccine)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA Investigational Vaccine
  • Phoenix, Arizona
  • +52 more
Jun 16, 2023

RSV Trial in United States (RSVpreF (Group 1), RSVpreF (Group 2), RSVpreF (Group 3))

Recruiting
  • RSV
  • RSVpreF (Group 1)
  • +3 more
  • Miami Lakes, Florida
  • +18 more
Mar 10, 2022

Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA investigational vaccine)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Mobile, Alabama
  • +45 more
Jul 22, 2022

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, Placebo)

Recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Placebo
  • Daphne, Alabama
  • +56 more
Jan 20, 2023

Healthy Participants Trial (Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF)

Not yet recruiting
  • Healthy Participants
  • Combination [RSVpreF+BNTb162b2]
  • +4 more
  • (no location specified)
May 31, 2023

Respiratory Syncytial Virus Trial in Australia (RSVpreF Vaccine, Placebo, Seasonal Inactivated Influenza Vaccine)

Recruiting
  • Respiratory Syncytial Virus
  • RSVpreF Vaccine
  • +2 more
  • Bruce, Australian Capital Territory, Australia
  • +31 more
Jul 7, 2022

Healthy Trial in Buenos Aires (RSVpreF+qIRV, qIRV, RSVpreF)

Recruiting
  • Healthy
  • RSVpreF+qIRV
  • +3 more
  • Buenos Aires, Argentina
    Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Mar 27, 2023

Respiratory Syncytial Virus Infections Trial in London (RSVPreF, Placebo)

Completed
  • Respiratory Syncytial Virus Infections
  • RSVPreF
  • Placebo
  • London, United Kingdom
    Golam Kabir
Sep 1, 2021

Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
  • Amsterdam, Netherlands
    The Amsterdam University Medical Centers
Aug 2, 2023

The Role of B7-H4 in Tumor Vaccine

Recruiting
  • Glioma
  • tumor vaccine
  • Shanghai, Shanghai, China
    Di Chen
Nov 26, 2023

COVID-19 Trial in Paris (Lymph node aspiration / Blood sampling)

Recruiting
  • COVID-19
  • Lymph node aspiration / Blood sampling
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 19, 2023

Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)

Not yet recruiting
  • Rabies
  • 5-dose group of test vaccine
  • +3 more
  • Chengdu, Sichuan, China
  • +3 more
Jul 23, 2023

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Quadrivalent Influenza Vaccine Immunization Schedule for

Completed
  • GCP
  • Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
  • Jinan, Shandong, China
    Kou Zengqiang
Oct 17, 2023